Sulfasalazine
CAS No. 599-79-1
Sulfasalazine( Azopyrin | NSC 203730 | NSC 667219 )
Catalog No. M15233 CAS No. 599-79-1
Sulfasalazine, a sulfa agent and a derivative of mesalazine, is used primarily as an anti-inflammatory agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 28 | In Stock |
|
| 500MG | 41 | In Stock |
|
| 1G | 49 | In Stock |
|
Biological Information
-
Product NameSulfasalazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionSulfasalazine, a sulfa agent and a derivative of mesalazine, is used primarily as an anti-inflammatory agent.
-
DescriptionSulfasalazine, a sulfa agent and a derivative of mesalazine, is used primarily as an anti-inflammatory agent. Target: Others Sulfasalazine (Azulfidine), used to treat pain and swelling in arthritis, belongs to a class of drugs called sulfa drugs.(In Vitro):Treatment of SW620 colon cells with sulfasalazine inhibits TNFα-, LPS-, or phorbol ester-induced NFκB activation. NFκB-dependent transcription is inhibited by sulfasalazine at micro- to millimolar concentrations. TNFα-induced nuclear translocation of NFκB is prevented by sulfasalazine through inhibition of IκBα degradation. Pre-incubation with 5 mM of sulfasalazine alone significantly increases basal mRNA expression of all pro-inflammatory cytokines with levels of IL-6 mRNA increased by 80-fold compared with vehicle control. Once digested, sulfasalazine is cleaved into sulfapyridine and 5-aminosalicylic acid by colonic bacteria, and the latter, too, is reported to suppress NF-kappaB activity.(In Vivo):At low doses (0.25 mM), SAS is able to suppress glioma growth by over 60% compared to untreated controls.
-
In VitroTreatment of SW620 colon cells with sulfasalazine inhibits TNFα-, LPS-, or phorbol ester-induced NFκB activation. NFκB-dependent transcription is inhibited by sulfasalazine at micro- to millimolar concentrations. TNFα-induced nuclear translocation of NFκB is prevented by sulfasalazine through inhibition of IκBα degradation. Pre-incubation with 5 mM of sulfasalazine alone significantly increases basal mRNA expression of all pro-inflammatory cytokines with levels of IL-6 mRNA increased by 80-fold compared with vehicle control. Once digested, sulfasalazine is cleaved into sulfapyridine and 5-aminosalicylic acid by colonic bacteria, and the latter, too, is reported to suppress NF-kappaB activity.
-
In VivoAt low doses (0.25 mM), SAS is able to suppress glioma growth by over 60% compared to untreated controls.
-
SynonymsAzopyrin | NSC 203730 | NSC 667219
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-1| COX-2| NF-κB
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number599-79-1
-
Formula Weight398.39
-
Molecular FormulaC18H14N4O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 80 mg/mL (200.8 mM)
-
SMILESO=C(O)C1=CC(/N=N/C2=CC=C(S(=O)(NC3=NC=CC=C3)=O)C=C2)=CC=C1O
-
Chemical Name(E)-2-hydroxy-5-((4-(N-(pyridin-2-yl)sulfamoyl)phenyl)diazenyl)benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Weber CK, et al. Gastroenterology. 2000 Nov;119(5):1209-18.
molnova catalog
related products
-
Thonzylamine
Thonzylamine is an antihistamine and anticholinergic drug. It is available as combination products with Clofedanol or Phenylephrine for temporary relief of symptoms of common cold, hay fever (allergic rhinitis) or other upper respiratory allergies.
-
Hamaline
Hamaline is a substrate-selective cyclooxygenase-2 (COX-2) inhibitor.
-
Vitacoxib
A potent, selective COX-2 inhibitor with IC50 of 0.34 ug/mL.
Cart
sales@molnova.com